BNP Paribas Financial Markets
CRDF icon

BNP Paribas Financial Markets’s Cardiff Oncology CRDF Stock Holding History

BNP Paribas Financial Markets’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$297K Buy
228,461
+215,385
+1,647% +$342K ﹤0.01% 4041
2026
Q1 		$21.2K Buy
13,076
+436
+3% +$895 ﹤0.01% 5072
2025
Q4 		$35.5K Buy
12,640
+1,058
+9% +$2.46K ﹤0.01% 4830
2025
Q3 		$23.9K Sell
11,582
-3,855
-25% -$10.7K ﹤0.01% 4867
2025
Q2 		$48.6K Buy
15,437
+11,889
+335% +$36.3K ﹤0.01% 4267
2025
Q1 		$11.1K Sell
3,548
-2,185
-38% -$8.64K ﹤0.01% 4692
2024
Q4 		$24.9K Buy
+5,733
New +$17.9K ﹤0.01% 4672
2019
Q4 		– Sell
-1
Closed -$2 – 4433
2019
Q3 		$2 Hold
1
– – ﹤0.01% 4503
2019
Q2 		$2 Buy
+1
New +$3 ﹤0.01% 4528
2019
Q1 		– Hold
0
– -$1 – 4305
2018
Q4 		– Hold
0
– – – 4317
2018
Q3 		– Hold
0
– – – 4433
2018
Q2 		– Hold
0
– -$7 – 4433
2018
Q1 		– Hold
0
– – – 4202
2017
Q4 		– Hold
0
– – – 4211
2017
Q3 		– Hold
0
– – – 4202
2017
Q2 		– Sell
-2
Closed -$129 – 4204
2017
Q1 		$145 Sell
2
-19
-90% -$2.58K ﹤0.01% 3973
2016
Q4 		$3.15K Sell
21
-5
-19% -$1.17K ﹤0.01% 3840
2016
Q3 		$8.48K Buy
26
+5
+24% +$1.82K ﹤0.01% 3251
2016
Q2 		$6.7K Buy
+21
New +$7.23K ﹤0.01% 3117
2016
Q1 		– Sell
-105
Closed -$40.7K – 2752
2015
Q4 		$40.7K Buy
105
+9
+9% +$3.52K ﹤0.01% 2953
2015
Q3 		$39.3K Buy
96
+68
+243% +$35.6K ﹤0.01% 3033
2015
Q2 		$20.6K Buy
+28
New +$19.9K ﹤0.01% 3036
2014
Q3 		– Sell
-8
Closed -$2.03K – 4118
2014
Q2 		$2.03K Hold
8
– – ﹤0.01% 3094
2014
Q1 		$3.27K Hold
8
– – ﹤0.01% 2521
2013
Q4 		$3.33K Buy
+8
New +$3.56K ﹤0.01% 3359

Other funds holding CRDF

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BNP Paribas Financial Markets's CRDF Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Cardiff Oncology (CRDF) stake by 1,647% in Q2 2026, buying an estimated $342K and bringing the position to 228,461 shares worth $297K. The position accounts for ﹤0.01% of the portfolio, ranked #4041.

BNP Paribas Financial Markets first reported a position in CRDF in Q4 2013 and has held it in 19 quarters since. 98 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • BNP Paribas Financial Markets held 228,461 shares of Cardiff Oncology worth $297K as of Q2 2026.
  • BNP Paribas Financial Markets bought 215,385 Cardiff Oncology shares in Q2 2026, an estimated $342K.
  • Cardiff Oncology made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4041 holding.
  • BNP Paribas Financial Markets first reported a position in Cardiff Oncology in Q4 2013 and has held it in 19 quarters since.
  • 98 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.